Feb 26, 2026 07:00AM
Feb 17, 2026 07:00AM
Jan 8, 2026 07:05AM
Jan 8, 2026 07:00AM
Dec 19, 2025 09:06AM
Mar 25, 2025 06:51AM
Mar 24, 2025 01:50PM Oppenheimer Reiterates Outperform Rating on Entrada Therapeutics (TRDA)
Mar 24, 2025 09:15AM
Mar 24, 2025 07:01AM
Mar 24, 2025 07:00AM
Feb 28, 2025 12:43AM
Feb 27, 2025 07:00AM
Feb 25, 2025 06:49AM
Feb 24, 2025 07:00AM Entrada Therapeutics (TRDA) Announces FDA Removal of Clinical Hold on ENTR-601-44
Feb 24, 2025 07:00AM
Mar 13, 2024 07:00AM
Nov 22, 2023 07:23AM
Nov 22, 2023 07:00AM
Nov 7, 2023 07:00AM
Aug 8, 2023 07:00AM
May 10, 2023 07:00AM Entrada Therapeutics Reports First Quarter 2023 Financial Results
Mar 23, 2023 10:19AM
Mar 6, 2023 07:00AM
Mar 6, 2023 07:00AM
Dec 19, 2022 05:38PM
Dec 19, 2022 04:30PM
Dec 19, 2022 04:30PM
Dec 19, 2022 04:30PM Entrada Therapeutics Announces Clinical Hold on IND Application for ENTR-601-44 in Duchenne Muscular Dystrophy
Nov 7, 2022 07:00AM
Nov 7, 2022 07:00AM
Aug 11, 2022 07:00AM
Aug 11, 2022 07:00AM
Aug 4, 2022 07:05AM
Aug 4, 2022 07:00AM
Aug 4, 2022 07:00AM Entrada Therapeutics Announces Collaboration with the Myotonic Dystrophy Clinical Research Network to Study the Natural History of Myotonic Dystrophy Type 1
May 12, 2022 07:03AM
May 12, 2022 07:00AM
May 12, 2022 07:00AM
May 11, 2022 09:32AM
May 11, 2022 09:30AM
May 11, 2022 09:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All